IDO1 and neoplasm: Reversing IDO1-mediated immunosuppression improved responses to immunogenic chemotherapy in a subcutaneous colorectal tumor model by promoting dendritic cell maturation, increasing tumor infiltrating T lymphocytes, and decreasing the numbers of regulatory T cells [31].